Showing results (51-60 of 1,307) with videos related to
Sort By:
Pageof 131
Respiratory Medicine|August 18, 2009
Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in GermanyR Diel, T Schaberg, R Loddenkemper, et al.Pneumologie (Stuttgart, Germany)|November 17, 2020
[125 Years German Central Committee for the Fight against Tuberculosis (DZK)]R Loddenkemper, N Konietzko, V Seehausen, et al.Pneumologie (Stuttgart, Germany)|May 1, 1992
[In vitro studies of cellular immunity in chronic bronchitis with and without corticosteroid medication]N Schönfeld, N Remy, P Bartmann, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 1, 1993
Studies on lymphocyte characteristics in patients with homozygous alpha 1-proteinase inhibitor deficiency during substitution therapyN Schoenfeld, M Schmitt, N Remy, et al.Pneumologie (Stuttgart, Germany)|February 1, 1990
[Value of magnetic resonance tomography in Pancoast and other tumors with infiltration of the thoracic wall]R Bittner, D Kaiser, R Loddenkemper, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 28, 1998
Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft für die Therapie von LungenkrankheitanR Loddenkemper, A Kloppenborg, N Schoenfeld, et al.Pneumologie (Stuttgart, Germany)|June 12, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]R Diel, B Hauer, R Loddenkemper, et al.Pneumologie (Stuttgart, Germany)|December 22, 1999
[Bronchial carcinoma in young adults]N Schönfeld, T Lienert, M Serke, et al.Pneumologie (Stuttgart, Germany)|June 23, 2007
[The current status of tuberculosis in Germany and impact of the global situation]F Kunitz, B Brodhun, B Hauer, et al.Zeitschrift Fur Rheumatologie|June 11, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]R Diel, B Hauer, R Loddenkemper, et al.Pageof 131